Full name
NOVA - PHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
32 - Other manufacturing of products
46 - Wholesale trade
49.41 - Road freight transport
52 - Warehousing, storage, and support activities for transport
68 - Real estate activities
70.2 - Business and management consultancy activities
77 - Rental and leasing
86 - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,3 | -0,1 | 0,1 | 372,5 |
EBITDA | -0,3 | -0 | 0,2 | 480,4 |
Short time liabilities | 0,6 | 0,9 | 0,6 | -29,3 |
Equity capital | -0,1 | -0,2 | -0 | 81,9 |
Operating profit (EBIT) | -0,3 | -0,1 | 0,1 | 376,6 |
Assets | 0,9 | 1,2 | 1 | -12 |
Net profit (loss) | -0,3 | -0,1 | 0,1 | 372,5 |
Cash | 0,1 | 0,2 | 0,1 | -37,8 |
Net income from sale | 4,2 | 5,8 | 6 | 2,5 |
Liabilities and provisions for liabilities | 1 | 1,3 | 1,1 | -21,2 |
Working assets | 0,7 | 1,1 | 0,9 | -13,5 |
Depreciation | 0 | 0 | 0 | -48,4 |
% | % | % | p.p. | |
Profitability of capital | 243,6 | 30,1 | -453,5 | -483,6 |
Equity capital to total assets | -14,3 | -15,1 | -3,1 | 12 |
Gross profit margin | -7,2 | -0,9 | 2,4 | 3,3 |
EBITDA Margin | -6,6 | -0,7 | 2,5 | 3,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 56 | 57 | 39 | -18 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane